REST is a novel prognostic factor and therapeutic target for medulloblastoma
about
The REST gene signature predicts drug sensitivity in neuroblastoma cell lines and is significantly associated with neuroblastoma tumor stage.Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive diseaseExtensive alternative splicing of the repressor element silencing transcription factor linked to cancer.Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cellsSignals that regulate the oncogenic fate of neural stem cells and progenitorsNeuroprotective effects of psychotropic drugs in Huntington's diseaseTargeting of histone deacetylases in brain tumors.NRSF: an angel or a devil in neurogenesis and neurological diseases.Medulloblastoma development: tumor biology informs treatment decisionsEvolving molecular era of childhood medulloblastoma: time to revisit therapy.The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma.REST Final-Exon-Truncating Mutations Cause Hereditary Gingival Fibromatosis.Epigenetic regulation in medulloblastoma.REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature.Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation.Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.REST, not REST4, is a risk factor associated with radiotherapy plus chemotherapy efficacy in glioma.Pharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migration
P2860
Q34072154-9E337877-DE0D-4ADC-921B-5C25F275D91AQ34284039-A5425D14-FADD-43EA-A411-84FCA3349BEEQ34502522-C249B492-1178-4E92-A01F-084D03E1E38FQ34685755-4DB4DA73-0E43-402D-820A-D08636511C4BQ36719626-2B83099E-9174-4215-9AC8-02920CD787C9Q38078705-36A19D94-61A3-4272-9C69-11BE772C5FE5Q38163877-516F3CAC-7BCD-4907-9726-29C12B9B40C6Q38233117-91550722-1A1F-45A3-A53D-871108D9D991Q38283875-829E73D8-85B5-4DBF-99C9-5C2CB1DD1B02Q38376606-36A0734A-D990-4AA3-AF90-D111D554BAA7Q38652681-B00CF9F2-9911-48F2-B960-5D6749AA648DQ39091713-B86D9F64-E179-4748-B592-7FA4C6E2345AQ47158974-36DCF973-7468-4D69-90F6-16FD39AC10D8Q47900778-CA69754B-51B7-449F-9CDA-3412B75C6B99Q49562927-7AA305C4-01F7-4685-88D9-C2A5E8546976Q52095907-012A5756-2176-43C6-A2A7-763E6D8F655AQ52097904-526193ED-6D13-4DBB-8C0E-0EB76D35280BQ55264621-AD4184AA-58C6-4A66-B8EF-2A74F4A0440AQ58725240-5E5A24FF-9047-4F35-A2B7-ABA2151194D7
P2860
REST is a novel prognostic factor and therapeutic target for medulloblastoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
REST is a novel prognostic factor and therapeutic target for medulloblastoma
@en
REST is a novel prognostic factor and therapeutic target for medulloblastoma.
@nl
type
label
REST is a novel prognostic factor and therapeutic target for medulloblastoma
@en
REST is a novel prognostic factor and therapeutic target for medulloblastoma.
@nl
prefLabel
REST is a novel prognostic factor and therapeutic target for medulloblastoma
@en
REST is a novel prognostic factor and therapeutic target for medulloblastoma.
@nl
P2093
P2860
P1476
REST is a novel prognostic factor and therapeutic target for medulloblastoma
@en
P2093
Alvaro Laureano
Irene B Helenowski
Jason Fangusaro
Laurence Cooper
Pete Taylor
Stewart Goldman
Tobey MacDonald
Veena Rajaram
Vidya Gopalakrishnan
P2860
P304
P356
10.1158/1535-7163.MCT-11-0990
P577
2012-07-30T00:00:00Z